Increased body fat mass and suppression of circulating leptin levels in response to hypersecretion of epinephrine in phenylethanolamine-N-methyltransferase (PNMT)-overexpressing mice

被引:23
作者
Böttner, A
Haidan, A
Eisenhofer, G
Kristensen, K
Castle, AL
Scherbaum, WA
Schneider, H
Chrousos, GP
Bornstein, SR
机构
[1] Univ Leipzig, Dept Internal Med 3, D-04103 Leipzig, Germany
[2] NINDS, Intramural Res Program, NIH, Bethesda, MD 20892 USA
[3] NIDDKD, NIH, Bethesda, MD 20892 USA
[4] NICHHD, NIH, Bethesda, MD 20892 USA
[5] Pipeline Biotech AS, Silkeborg, Denmark
[6] Diabet Res Inst, D-40225 Dusseldorf, Germany
[7] Univ Erlangen Nurnberg, Childrens Hosp, D-91054 Erlangen, Germany
关键词
D O I
10.1210/en.141.11.4239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epinephrine is a major stress hormone that plays a central role in the control of metabolic function and energy homeostasis. To evaluate the role of epinephrine and the physiological and pathophysiological consequences of sustained elevation of epinephrine on metabolic and endocrine function, we studied several metabolic parameters and circulating leptin levels in a newly developed transgenic mouse model of phenylethanolamine-N-methyltransferase (PNMT) overexpression. A 100-fold overexpression of PNMT and subsequent elevation of epinephrine levels resulted in a marked suppression of circulating leptin levels in the transgenic animals (1.14 +/- 0.05 vs. 2.17 +/- 0.35 ng/ml; P < 0.01), which correlated negatively with plasma epinephrine (r = -0.82; P ( 0.05), thus providing evidence for an inhibitory action of epinephrine on leptin production in vivo. In parallel, we found a marked increase in the body fat content of the transgenic animals (12.54 +/- 1.5 vs. 6.22 +/- 0.2%; P < 0.01) that was accompanied by enlarged adipocytes, indicating an increased lipid storage in PNMT transgenic mice. Interestingly, however, transgenic animals had normal body weight and did not exhibit major alterations in carbohydrate metabolism, as evidenced by analysis of random and fasted blood glucose levels, plasma insulin and C peptide levels, and insulin tolerance test. The metabolic alterations observed were not secondary to changes in food intake or increased activity of the hypothalamic-pituitary-adrenal axis, as there were no differences in these parameters. In summary, sustained primary overproduction of epinephrine resulted in suppression of plasma leptin levels and increased lipid storage in the PNMT transgenic mice. The concerted action of the sympathoadrenal system and reduced leptin may contribute to defending energy reservoirs while maintaining a normal body weight, which may be of vital importance under conditions of stress and energy deficiency.
引用
收藏
页码:4239 / 4246
页数:8
相关论文
共 46 条
  • [1] Role of leptin in the neuroendocrine response to fasting
    Ahima, RS
    Prabakaran, D
    Mantzoros, C
    Qu, DQ
    Lowell, B
    MaratosFlier, E
    Flier, JS
    [J]. NATURE, 1996, 382 (6588) : 250 - 252
  • [2] Knocking out the stress response
    Bornstein, SR
    Böttner, A
    Chrousos, GP
    [J]. MOLECULAR PSYCHIATRY, 1999, 4 (05) : 403 - 407
  • [3] Plasma leptin levels are increased in survivors of acute sepsis: Associated loss of diurnal rhythm in cortisol and leptin secretion
    Bornstein, SR
    Licinio, J
    Tauchnitz, R
    Engelmann, L
    Negrao, AB
    Gold, P
    Chrousos, GP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) : 280 - 283
  • [4] Is leptin a stress related peptide?
    Bornstein, SR
    [J]. NATURE MEDICINE, 1997, 3 (09) : 937 - 937
  • [5] Hyperleptinaemia does not correlate with plasma catecholamine levels in chronic heart failure
    Böttner, A
    Eisenhofer, G
    Friberg, P
    Rundqvist, B
    Bornstein, SR
    [J]. EUROPEAN HEART JOURNAL, 1999, 20 (14) : 1051 - 1052
  • [6] Lack of leptin suppression in response to hypersecretion of catecholamines in pheochromocytoma patients
    Böttner, A
    Eisenhofer, G
    Torpy, DJ
    Ehrhart-Bornstein, M
    Keiser, HR
    Chrousos, GP
    Bornstein, SR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (05): : 543 - 545
  • [7] BOTTNER A, 1996, 81 ANN M END SOC SAN, pP2
  • [8] In vivo resistance of lipolysis to epinephrine - A new feature of childhood onset obesity
    Bougneres, P
    LeStunff, C
    Pecqueur, C
    Pinglier, E
    Adnot, P
    Ricquier, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (11) : 2568 - 2573
  • [9] BRAY GA, 1990, INT J OBESITY, V14, P77
  • [10] INTRONS INCREASE TRANSCRIPTIONAL EFFICIENCY IN TRANSGENIC MICE
    BRINSTER, RL
    ALLEN, JM
    BEHRINGER, RR
    GELINAS, RE
    PALMITER, RD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) : 836 - 840